Skip to main content
. 2024 Sep 17;38(11):2443–2455. doi: 10.1038/s41375-024-02411-7

Fig. 1. Clinical outcome and toxicity data.

Fig. 1

A Treatment status at time of data collection, B best response achieved on asciminib, C haematological toxicity and D non-haematological toxicity. CCyR: complete cytogenetic response (BCR::ABL1 IS level ≤ 1%), MMR, major molecular response (BCR::ABL1 IS level ≤ 0.1%), MR4, BCR::ABL1 IS level ≤ 0.01% IS, MR4.5, BCR::ABL1 IS level ≤ 0.0032% IS, LFT: liver function tests, DR: dose reduction, IS: international scale.